Bioxytran, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-318.4K | $-696.8K | $-2.1M | $-1.3M | $-1.8M | $-2.3M | $-4.4M | $-336.5K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $17.5K | $27.6K | $54.8K | $58.2K | $51.1K | $40.6K | $30.7K | $3.4K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-18.5K | $-42.4K | $-2.7K | $-16.3K | $9.3K | $-63.7K | $-398.8K | $-75.8K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | $-87.3K | $-2.1K | $-148.0K | $-46.2K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $22.7K | $50.0K | — | $1.8K | $93.2K | $54.8K | $540.5K | $139.0K |
| Net Change in Cash | $4.2K | $7.6K | $-2.7K | $-14.5K | $15.2K | $-11.0K | $-6.2K | $17.0K |
| Free Cash Flow | — | — | — | — | — | — | — | — |